Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSEEGO CORP.INSG · Entity 7061 | Director | September 29, 2023 | October 04, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSEEGO CORP.
Report date September 29, 2023 · Filed October 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 293,912 |
Reported balance
After 2023-09-29 transaction · row 1
1 source rowRow 1 · 2023-09-29 · Grant · Acquired 215,517 · Balance 293,912 F1: Represents restricted stock units ("RSUs") that settle for shares of common stock on a 1-for-1 basis. The RSUs are scheduled to vest on September 5, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") that settle for shares of common stock on a 1-for-1 basis. The RSUs are scheduled to vest on September 5, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2023 Filed Oct 4, 2023 00:31 UTC | INSEEGO CORP. INSG · Entity 7061 | GrantCommon Stock | 215,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-006949 · ownership.xml · nonDerivative · entry 1 Bowers Stephanie Lynne · CIK 0001895950 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,912 F1 · shares: Represents restricted stock units ("RSUs") that settle for shares of common stock on a 1-for-1 basis. The RSUs are scheduled to vest on September 5, 2024. Read SEC document |
| August 03, 2022 Filed Aug 6, 2022 00:33 UTC | INSEEGO CORP. INSG · Entity 7061 | GrantCommon Stock | 49,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-22-005383 · ownership.xml · nonDerivative · entry 1 Bowers Stephanie Lynne · CIK 0001895950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,395 F1 · shares: Represents restricted stock units scheduled to vest the one-year anniversary of the grant date. F2 · shares: The restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| July 28, 2021 Filed Dec 7, 2021 01:30 UTC | INSEEGO CORP. INSG · Entity 7061 | GrantCommon Stock | 14,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-21-006134 · ownership.xml · nonDerivative · entry 2 Bowers Stephanie Lynne · CIK 0001895950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,594 F2 · shares: Represents restricted stock units scheduled to vest in full on the first anniversary of the grant date. Read SEC document |
| June 15, 2021 Filed Dec 7, 2021 01:30 UTC | INSEEGO CORP. INSG · Entity 7061 | GrantCommon Stock | 13,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-21-006134 · ownership.xml · nonDerivative · entry 1 Bowers Stephanie Lynne · CIK 0001895950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,373 F1 · shares: Represents restricted stock units scheduled to vest over a three-year period, with one-third vesting on each anniversary of the grant date through the third anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.